Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Monte Rosa to Receive $50 Million Milestone Payment From Novartis for Phase 2 Launch of MRT-6160

Monte Rosa to Receive $50 Million Milestone Payment From Novartis for Phase 2 Launch of MRT-6160

MT newswireMT newswire2026/09/08 12:18
08:18 AM EDT, 09/08/2026 (MT Newswires) -- Monte Rosa Therapeutics (GLUE) said Tuesday it will receive a $50 million milestone payment from Novartis (NVS) after initiating a phase 2 clinical trial of MRT-6160 to treat Sjogren's disease. The company said the payment is part of a licensing agreement between the companies under which it is eligible to receive up to $2.1 billion in development, regulatory and sales milestone payments. The trial is evaluating the drug's safety, tolerability and efficacy in people with Sjogren's disease, an autoimmune disease that impacts multiple organs and causes symptoms such as dryness, fatigue, pain, and an increased risk of lymphoma.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The U.S. Senate passes a landmark permitting reform bill to expedite grid and AI data center approvals

The U.S. Senate has passed a landmark bill that could comprehensively reform the country's energy permitting system.

智通财经•2026/11/20 06:43

Cracks in "AI trading" continue to appear, triggering a global stock sell-off, while US Treasuries are set for their longest rally in five months.

As concerns over artificial intelligence (AI) trading trends continue to deepen, the global stock market sell-off has intensified, leading investors to flock to safe-haven assets. As a result, US Treasuries are poised to experience their longest rally in nearly five months.

智通财经•2026/11/20 06:27